Adrian Dunlop
Adrian Dunlop
University of Newcastle
Verified email at - Homepage
Cited by
Cited by
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
IS Allsop, David J., Copeland, Jan, Lintzeris, Nicholas, Dunlop, Adrian J ...
JAMA Psychiatry 71 (3), 281-291, 2014
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study
M Alavi, J Grebely, M Micallef, AJ Dunlop, AC Balcomb, CA Day, ...
Clinical Infectious Diseases 57 (suppl_2), S62-S69, 2013
LAAM maintenance vs methadone maintenance for heroin dependence
NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling
Cochrane Database of Systematic Reviews, 2002
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
A Dunlop, B Lokuge, D Masters, M Sequeira, P Saul, G Dunlop, J Ryan, ...
Harm reduction journal 17 (1), 1-7, 2020
Concurrent buprenorphine and benzodiazepines use and self‐reported opioid toxicity in opioid substitution treatment
S Nielsen, P Dietze, N Lee, A Dunlop, D Taylor
Addiction 102 (4), 616-622, 2007
A randomized trial of effectiveness and cost‐effectiveness of observed versus unobserved administration of buprenorphine–naloxone for heroin dependence
J Bell, M Shanahan, C Mutch, F Rea, A Ryan, R Batey, A Dunlop, ...
Addiction 102 (12), 1899-1907, 2007
Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis
S Fraser, K Pienaar, E Dilkes-Frayne, D Moore, R Kokanovic, C Treloar, ...
International Journal of Drug Policy 44, 192-201, 2017
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study
J Grebely, M Alavi, M Micallef, AJ Dunlop, AC Balcomb, N Phung, ...
Addiction 111 (2), 311-319, 2016
National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence
N Lintzeris, N Clark, P Muhleisen, A Ritter, R Ali, J Bell, L Gowing, ...
Informa, 2009
Validation and implementation of the A ustralian Treatment Outcomes Profile in specialist drug and alcohol settings
A Ryan, J Holmes, V Hunt, A Dunlop, K Mammen, R Holland, Y Sutton, ...
Drug and Alcohol Review 33 (1), 33-42, 2014
National guidelines for medication-assisted treatment of opioid dependence
L Gowing, R Ali, A Dunlop, M Farrell, N Lintzeris
Canberra: Commonwealth of Australia, 38-9, 2014
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study
AD Marshall, M Micallef, A Erratt, J Telenta, C Treloar, H Everingham, ...
International Journal of Drug Policy 26 (10), 984-991, 2015
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
J Keats, M Micallef, J Grebely, S Hazelwood, H Everingham, N Shrestha, ...
International Journal of Drug Policy 26 (10), 999-1006, 2015
A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence
N Lintzeris, SY Leung, AJ Dunlop, B Larance, N White, GR Rivas, ...
Drug and alcohol dependence 131 (1-2), 119-126, 2013
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study
JA Kwon, GJ Dore, J Grebely, B Hajarizadeh, R Guy, EB Cunningham, ...
Journal of viral hepatitis 26 (1), 83-92, 2019
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder
M Frost, GL Bailey, N Lintzeris, J Strang, A Dunlop, EV Nunes, JB Jansen, ...
Addiction 114 (8), 1416-1426, 2019
Boundary violations, gender and the nature of nursing work
M Chiarella, A Adrian
Nursing Ethics 21 (3), 267-277, 2014
Changes in cigarette and alcohol use during cannabis abstinence
DJ Allsop, AJ Dunlop, C Sadler, GR Rivas, IS McGregor, J Copeland
Drug and alcohol dependence 138, 54-60, 2014
An iterative model for in vitro laboratory assessment of tamper deterrent formulations
EJ Cone, J Giordano, B Weingarten
Drug and alcohol dependence 131 (1-2), 100-105, 2013
The system can't perform the operation now. Try again later.
Articles 1–20